Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

csl behring gmbh - factor ii activity; factor vii activity; factor x activity; factor ix activity; protein c activity; protein s antigen - powder and solvent for solution for injection - 250 international unit(s) - blood coagulation factors; coagulation factor ix, ii, vii and x in combination

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

csl behring gmbh - factor ii activity; factor vii activity; factor x activity; factor ix activity; protein c activity; protein s antigen - powder and solvent for solution for injection - 500 international unit(s) - blood coagulation factors; coagulation factor ix, ii, vii and x in combination

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

csl behring gmbh - factor ii activity; factor vii activity; factor x activity; factor ix activity; protein c activity; protein s antigen - powder and solvent for solution for injection - 1000 international unit(s) - blood coagulation factors; coagulation factor ix, ii, vii and x in combination

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

octapharma (ip) sprl - factor ix, human - powder and solvent for solution for injection - 500 international unit(s) - blood coagulation factors; coagulation factor ix

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

octapharma (ip) sprl - factor ix, human - powder and solvent for solution for injection - 1000 international unit(s) - blood coagulation factors; coagulation factor ix

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - factor ix 1000 [iu] (100iu/ml when reconstituted with 10ml water for injection) - injection with diluent - 1000 iu - active: factor ix 1000 [iu] (100iu/ml when reconstituted with 10ml water for injection) excipient: antithrombin iii chloride citric acid monohydrate heparin phosphorus plasma protein fraction sodium water for injection - monofix®-vf is indicated for the treatment of haemorrhages, for use in surgery, and as prophylaxis in patients with haemophilia b. monofix®-vf is not indicated for the treatment of factor ii, vii or x deficiencies because it does not contain therapeutic levels of these coagulation factors. monofix®-vf is not indicated for the treatment of haemophilia a patients with factor viii inhibitors.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - factor ix 500 [iu] (human coagulation 100iu/ml when reconstituted with 5ml water for injections) - injection with diluent - 500 iu - active: factor ix 500 [iu] (human coagulation 100iu/ml when reconstituted with 5ml water for injections) excipient: antithrombin iii chloride citric acid monohydrate heparin phosphorus plasma protein fraction sodium water for injection - monofix®-vf is indicated for the treatment of haemorrhages, for use in surgery, and as prophylaxis in patients with haemophilia b. monofix®-vf is not indicated for the treatment of factor ii, vii or x deficiencies because it does not contain therapeutic levels of these coagulation factors. monofix®-vf is not indicated for the treatment of haemophilia a patients with factor viii inhibitors.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - factor ix 500 [iu] (50 iu/ml when reconstituted with 10 ml water for injections) - injection with diluent - 50 iu/ml - active: factor ix 500 [iu] (50 iu/ml when reconstituted with 10 ml water for injections) excipient: antithrombin iii chloride citric acid monohydrate heparin phosphorus plasma protein fraction sodium water for injection - monofix®-vf is indicated for the treatment of haemorrhages, for use in surgery, and as prophylaxis in patients with haemophilia b. monofix®-vf is not indicated for the treatment of factor ii, vii or x deficiencies because it does not contain therapeutic levels of these coagulation factors. monofix®-vf is not indicated for the treatment of haemophilia a patients with factor viii inhibitors.

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

octapharma ltd - factor ii; factor vii; factor ix; factor x; protein c; protein s - powder and solvent for solution for infusion - 490unit ; 330unit ; 500unit ; 480unit ; 380unit ; 390unit

Israel - Tiếng Anh - Ministry of Health

kamada ltd, israel - factor viii; von willebrand factor - powder for solution for injection - factor viii 500 iu/vial; von willebrand factor 1300 iu/vial - von willebrand factor and coagula-tion factor viii in combination - von willebrand factor and coagula-tion factor viii in combination - treatment and prophylaxis of bleeding with haemophilia a (congenital factor viii deficiency).